Encainide: Revision history

24 July 2021

• curprev 12:3012:30, 24 July 2021‎ Rossdonaldson1 talk contribs‎ 2,014 bytes +2‎ No edit summary

27 June 2021

• curprev 00:5400:54, 27 June 2021‎ Blsimpso talk contribs‎ 2,012 bytes +343‎ →‎Pharmacology
• curprev 00:5000:50, 27 June 2021‎ Blsimpso talk contribs‎ 1,669 bytes −26‎ →‎Mechanism of Action
• curprev 00:4900:49, 27 June 2021‎ Blsimpso talk contribs‎ 1,695 bytes +386‎ →‎Pharmacology
• curprev 00:3400:34, 27 June 2021‎ Blsimpso talk contribs‎ 1,309 bytes +48‎ →‎Common
• curprev 00:3300:33, 27 June 2021‎ Blsimpso talk contribs‎ 1,261 bytes +101‎ →‎Serious
• curprev 00:2300:23, 27 June 2021‎ Blsimpso talk contribs‎ 1,160 bytes +66‎ →‎Hepatic Dosing
• curprev 00:2000:20, 27 June 2021‎ Blsimpso talk contribs‎ 1,094 bytes +93‎ →‎Renal Dosing
• curprev 00:1700:17, 27 June 2021‎ Blsimpso talk contribs‎ 1,001 bytes +2‎ →‎Sustained Ventricular Tachycardia
• curprev 00:1400:14, 27 June 2021‎ Blsimpso talk contribs‎ 999 bytes +31‎ →‎Lactation risk
• curprev 00:1000:10, 27 June 2021‎ Blsimpso talk contribs‎ 968 bytes +10‎ →‎Pregnancy Rating

• curprev 00:0800:08, 27 June 2021‎ Blsimpso talk contribs‎ 958 bytes +958‎ Created page with "==Administration== *Type: Class IC antiarrhythmic (sodium channel blocker) *Dosage Forms: Capsules (25mg or 35mg) *Routes of Administration: PO *Common Trade Names: Enkaid ==..."